| Field | Specification |
|---|---|
| Target | |
| Alternative names | Stromelysin-1;SL-1;3.4.24.17;Matrix metalloproteinase-3;MMP-3;Transin-1;MMP3;STMY1; |
| UniProt # | |
| Host | |
| Clone | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | A synthesized peptide derived from human MMP3 |
| Molecular weight | |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Form | Liquid |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
Clone BBO-13 is a rabbit monoclonal antibody that recognizes stromelysin-1 (gene MMP3) in human, mouse and rat samples and is validated for Western blot, IHC and ICC/IF. The predicted molecular weight is 54.0 kDa, and the supplier reports an observed band at about 50 kDa.
Stromelysin-1 (MMP-3) is a matrix metalloproteinase with broad specificity that degrades fibronectin, laminin, proteoglycans and several collagens. It also activates other MMPs such as pro-MMP-9, and it is widely studied in arthritis, tissue remodeling and neuroinflammation.
| Target | Stromelysin-1 (gene MMP3; UniProt P08254, human) |
|---|---|
| Clone | BBO-13 |
| Host / Clonality / Isotype | Rabbit / Monoclonal / Rabbit IgG |
| Reactivity | Human, Mouse, Rat |
| Form | Liquid |
| Formulation | PBS (pH 7.4); 150 mM NaCl; 0.02% sodium azide; 50% glycerol; plus stabilizers |
| Calculated MW | 54.0 kDa |
| Observed MW | 50 kDa |
| Storage | Long term: −20 °C for up to 12 months. Frequent use: 4 °C for up to 1 month. Avoid repeated freeze–thaw cycles. |
Validated Applications
| Western blot | 1:500–1:2000 |
|---|---|
| Immunohistochemistry | 1:50–1:200 |
| Immunocytochemistry / Immunofluorescence | 1:50–1:200 |
Samples with a confirmed band (WB): rat PC-12 whole cellIHC: human liver cancer tissue.
Recommended loading (WB): 20–40 µg of total protein per lane.
Conditions in the example images (WB): 10% SDS-PAGE under reducing conditions, 30 µg lysate per lane, transfer to nitrocellulose membrane, blocking in 5% non-fat milk, primary antibody at 1:500 overnight at 4 °C, HRP-conjugated secondary antibody at 1:5000, ECL detection.
Samples with confirmed staining (ICC/IF): HeLa cells.
Immunogen
Synthetic peptide based on the sequence of human MMP3.
Reactivity Notes
The supplier lists reactivity with human, mouse and rat. UniProt places stromelysin-1 in the nucleus and cytoplasm. The samples tested by the supplier (listed above) are a practical starting point for positive controls.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Zhiqiang Li et al. (2026) Unlocking an Efficient SOD-to-CAT Catalytic Relay in a MOF Nanozyme via Dopamine-Driven Interfacial Nanoreconstruction for Osteoarthritis Therapy. Advanced Materials. 10.1002/adma.72747
He Zhiyi et al. (2024) Remodeling of the pro-inflammatory microenvironment in osteoarthritis via hydrogel-based photothermal therapy. Advanced Composites and Hybrid Materials. 10.1007/s42114-024-00835-4
Wan Junlai et al. (2023) Novel strategy of senescence elimination via toxicity-exempted kinome perturbations by nanoliposome-based thermosensitive hydrogel for osteoarthritis therapy. Advanced Composites and Hybrid Materials. 10.1007/s42114-023-00673-w
Xinbo Wei et al. (2025) Neutrophil Membrane-Engineered Extracellular Vesicles from Perivascular Adipose Tissue-Derived Stromal Cells for Atherosclerotic Lesion Resolution and Enhanced Vascular Graft Remodeling. Advanced Functional Materials. 10.1002/adfm.202503873
Guo Rui-Bo et al. (2025) Treatment of rheumatoid arthritis using dual-targeted and dual-response intelligent micelles: a “three birds with one stone” strategy. Journal of Nanobiotechnology. 10.1186/s12951-024-03085-0
Xingyu Zhou et al. (2025) Microneedle delivery of CAR-M-like engineered macrophages alleviates intervertebral disc degeneration through enhanced efferocytosis capacity. Cell Reports Medicine. 10.1016/j.xcrm.2025.102079
Wan Junlai et al. (2023) Injectable photocrosslinking spherical hydrogel-encapsulated targeting peptide-modified engineered exosomes for osteoarthritis therapy. Journal of Nanobiotechnology. 10.1186/s12951-023-02050-7
Yan Li et al. (2025) Synergistic Reversal of Inflammation-Mediated Degeneration in Intervertebral Discs: Phenylboric Acid-Grafted Hyaluronic Acid Hydrogel as an Anti-Oxidative Vehicle for Timp-3 Delivery and Promotion of Extracellular Matrix Synthesis. Acta Biomaterialia. 10.1016/j.actbio.2025.06.011
Sun Kai et al. (2024) IRF1 regulation of ZBP1 links mitochondrial DNA and chondrocyte damage in osteoarthritis. Cell Communication and Signaling. 10.1186/s12964-024-01744-1
Wenchao Wang et al. (2022) Iron overload promotes intervertebral disc degeneration via inducing oxidative stress and ferroptosis in endplate chondrocytes. Free Radical Biology and Medicine. 10.1016/j.freeradbiomed.2022.08.018
